Vincristine treatment reverses podocyte damage in focal segmental glomerulosclerosis
William J. Mason, Jennifer C. Chandler, Alice M. Gage, Gideon Pomeranz, Karen L. Price, Marilina Antonelou, Scott R Henderson, Laura Perin, Stefano Da Sacco, Alan David Salama, David Andrew Long, Ruth J. Pepper
This study shows vincristine treatment reduces podocyte damage in FSGS by preserving cytoskeletal structure and filtration barrier integrity.
Kidney International Reports · Aug 15, 2025Peer-reviewedCell Biology